Books in Immunology

41-50 of 717 results in All results

Autoimmunity, COVID-19, Post-COVID19 Syndrome and COVID-19 Vaccination

1st Edition
Volume 1
December 3, 2022
Yehuda Shoenfeld + 1 more
English
Paperback
9 7 8 - 0 - 4 4 3 - 1 8 5 6 6 - 3
eBook
9 7 8 - 0 - 4 4 3 - 1 8 5 6 7 - 0

Autoimmunity, COVID-19, Post-COVID-19 Syndrome and COVID-19 Vaccination covers all aspects of what is perhaps the most dramatic health crisis in the history of modern medicine. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) raised major concerns about the association between the virus and various autoimmune manifestations. Over 15 distinct autoantibodies and above 10 different autoimmune diseases were found to develop in COVID-19 patients. Moreover, evidence about recovered COVID-19 patients demonstrates that persistent systemic symptoms, which are believed to have an autoimmune-related mechanism, do exist. As it is of great importance to recognize those autoimmune manifestations of COVID-19 and post-COVID-19 syndrome to properly cope with their outcomes in the ongoing pandemic and the long-term post-pandemic period, this book fulfills a vital need in the medical community.

Advances in Immunology

1st Edition
Volume 156
November 19, 2022
Frederick W. Alt + 1 more
English
Hardback
9 7 8 - 0 - 3 2 3 - 9 8 9 4 7 - 3
eBook
9 7 8 - 0 - 3 2 3 - 9 8 9 4 8 - 0

Advances in Immunology, Volume 156, the latest release in a long-established and highly respected publication, presents current developments and comprehensive reviews in immunology, with this volume covering self-referential immune recognition through C-type lectin receptors, genetic susceptibility to autoimmunity, activation and regulation of the cGAS-STING pathway and the implications of IL-15 trans-presentation on the immune response.

Advances in Immunology

1st Edition
Volume 155
November 7, 2022
Frederick W. Alt + 1 more
English
Hardback
9 7 8 - 0 - 3 2 3 - 9 8 9 4 5 - 9
eBook
9 7 8 - 0 - 3 2 3 - 9 8 9 4 6 - 6

Advances in Immunology, Volume 155, the latest release in this ongoing serial, highlights new advances in the field with this new volume presenting interesting chapters written by an international board of authors. Sections of note cover B cell/GC material.

Allergic and Immunologic Diseases

1st Edition
October 14, 2022
Christopher Chang
English
Paperback
9 7 8 - 0 - 3 2 3 - 9 5 0 6 1 - 9
eBook
9 7 8 - 0 - 3 2 3 - 9 5 3 2 3 - 8

Allergic and Immunologic Diseases: A Practical Guide to the Evaluation, Diagnosis and Management of Allergic and Immunologic Diseases is a valuable resource for researchers and others involved in the day-to-day practice of allergy and immunology, with specific information, protocols and algorithms to guide their thinking. The book provides practical information and an explanation of why and how we do things, while also addressing the limitations of testing and treatment. Other sections focus on scientific based practices and the known pathophysiology of allergic and immunologic diseases, along with mechanisms of action in various treatment modalities. This book is unique in that it explains the rationale behind everything we do in allergy and immunology, hence it offers readers specific information on procedures and how to order tests and treat allergic and immunologic diseases.

Immunological Implications and Molecular Diagnostics of Genitourinary Cancer

1st Edition
October 7, 2022
Moulay Mustapha Ennaji
English
Paperback
9 7 8 - 0 - 3 2 3 - 8 5 4 9 6 - 2
eBook
9 7 8 - 0 - 3 2 3 - 8 5 4 9 7 - 9

Immunological Implications and Molecular Diagnostics of Genitourinary Cancer updates on recent accomplishments, unifying concepts, and future challenges in the study of tumor-associated immune cells, emphasizing genitourinary cancers. The presence of inflammatory immune cells in human tumors raise a fundamental question: How do cancer cells avoid destruction by immune attack? In principle, tumor development can be controlled by cytotoxic innate and adaptive immune cells, however, as tumors develop from neoplastic tissue to clinically detectable tumors, cancer cells evolve different mechanisms. This book covers research on the immunological implications of genitourinary cancer with a comprehensive view, especially surrounding diagnosis and cellular mechanisms.

Translational Autoimmunity, Volume 5

1st Edition
September 13, 2022
Nima Rezaei
English
Paperback
9 7 8 - 0 - 3 2 3 - 8 5 3 8 9 - 7
eBook
9 7 8 - 0 - 3 2 3 - 8 5 3 9 0 - 3

Translational Autoimmunity: Challenges for Autoimmune Diseases, Fifth Edition addresses diagnostic approaches, therapeutic opportunities, and prognostic markers of different autoimmune diseases. This updated volume discusses autotoxicity, systems immunology, the prognostic significance of disease-specific autoantibodies, along with translational research to novel therapeutic policy in autoimmune diseases. From an introduction, to challenges and insights on the systems immunology of infectious and autoimmune diseases, new targets of treatments, and the role of autoantibodies in diagnosis and evolution, this book provides insights on many challenges researchers and clinicians are facing.

Advances in Immunology

1st Edition
Volume 154
August 26, 2022
Frederick W. Alt
English
Hardback
9 7 8 - 0 - 3 2 3 - 9 8 9 4 3 - 5
eBook
9 7 8 - 0 - 3 2 3 - 9 8 9 4 4 - 2

Advances in Immunology, Volume 154, the latest release in a long-established and highly respected publication, presents current developments and comprehensive reviews in immunology, with this volume covering Regulatory T Cells in Infection and Factor H and Properdin and their regulation.

System Vaccinology

1st Edition
August 20, 2022
Vijay Kumar Prajapati
English
Paperback
9 7 8 - 0 - 3 2 3 - 8 5 9 4 1 - 7
eBook
9 7 8 - 0 - 3 2 3 - 8 9 7 8 6 - 0

Emergence of new and deadly infectious diseases is significantly deteriorating the human health. Development of vaccine by the scientist has become an important weapon to control the spread of infectious diseases as well as to improve the life expectancy at global level in 20th-21st Century. This book will provide the in-depth knowledge of vaccine history, and development of new strategies to design efficacious and safe vaccine molecule. This book will cover the development of system vaccinology and their applications revolutionize the vaccine discovery. This will provide a resource for the basic and clinical researcher working to human life expectancy by their vaccine experiments and clinical trials. My purpose to write this book to educate the students and researchers with modern development in the field of vaccinology and empowering the researcher with new tools and methodology for developing potential and immunogenic vaccines. This book will be helpful to solve the curiosity of science and medical background students related with vaccinology and will be helpful to devise a new vaccine molecule to control the spread of new and emerging pathogens. Systems biology is a rapidly expanding research discipline aiming to integrate multifaceted datasets generated using state-of-the-art high- throughput technologies such as arrays and next-generation sequencing. Combined with sophisticated computational analysis we are able to interrogate host responses to infections and vaccination on a systems level, thus generating important new hypotheses and discovering unknown associations between immunological parameters.

Clinical Immunology

1st Edition
August 16, 2022
Nima Rezaei
English
Paperback
9 7 8 - 0 - 1 2 - 8 1 8 0 0 6 - 8
eBook
9 7 8 - 0 - 1 2 - 8 1 8 0 0 7 - 5

Clinical Immunology not only introduces the reader to the human immune system, it also covers immunology from clinical manifestation to therapeutic approaches in a wide range of conditions. Each chapter describes an introduction, the clinical manifestations, the immunopathogenesis, diagnosis, lab tests and therapeutic approaches. The book guides clinicians, researchers and students to a better understanding of the matters of immunologic-based diseases that can lead to better decision-making for patients.Because of the growing knowledge regarding the function of immune system in health and disease conditions, clinicians, researchers and students increasingly require an exclusive scientific reference to guide them on matters of immunologic-based diseases. Accordingly, despite the existence of numerous high quality references in basic and cellular/molecular immunology which deeply explain different immunologic mechanisms, there is still a knowledge gap in the field of clinical immunology.

Hepatobiliary Cancers: Translational Advances and Molecular Medicine

1st Edition
Volume 156
August 10, 2022
Alphonse E. Sirica + 1 more
English
Hardback
9 7 8 - 0 - 3 2 3 - 9 8 3 9 2 - 1
eBook
9 7 8 - 0 - 3 2 3 - 9 8 3 9 3 - 8

Hepatobiliary cancer refers to primary malignant tumors originating in cells of the liver, bile ducts, and gallbladder. Globally, primary liver cancer, which includes hepatocellular carcinoma (~75 % of all cases) and intrahepatic biliary cancer or cholangiocarcinoma (~10-15 % 0f all cases) is the 6th most commonly diagnosed cancer and 3rd leading cause of cancer deaths worldwide. The vast majority of these highly malignant cancers are diagnosed at an advanced stage where treatment options are limited and patient survival outcomes are poor. The biological and therapeutic challenges posed by hepatobililiary cancers such as hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) are daunting, emphasizing a critical need to review and assess current and evolving basic, translational, and clinical research focused on addressing the critical obstacles that continue to limit progress towards achieving significant improvements in HCC and CCA clinical management and patient survival outcomes. Towards this goal, this special edition of Advances in Cancer Research is focused on providing a comprehensive, timely and authoritative reviews covering such topics of significant scientific and clinical relevance, including hepatobiliary cancer risk mechanisms and risk-predictive molecular biomarkers; causes and functional intricacies of inter- and intratumor heterogeneity; novel insights into the role of tumor microenvironment and key signaling pathways in promoting hepatobiliary cancer progression, therapeutic resistance and immunosuppression; emerging biomarkers of HCC and CCA prognosis; advances in molecular genomics for personalizing tumor classification and targeted therapies; innovative preclinical cell culture modeling for hepatobiliary cancer drug discovery; and current and emerging trends in hepatobiliary cancer molecular therapeutic targeting and immunotherapies.